Industry Outlook
The amniocentesis needles market is set to reach from US$ 166.0 Mn in 2020 to US$ 218.5 Mn by 2029 at a compound annual growth rate (CAGR) of 3.1% during the forecast period from 2021 to 2029. Amniocentesis is frequently performed in prenatal diagnosis to identify any chromosomal abnormalities, neural tube defect and fetal infections during pregnancy. Rising public health awareness and implementation of effective health guidelines pertaining to obstetrics and gynecology drive the amniocentesis needles market growth.
"Optimal length and availability in different gauge increases the popularity of 100 to 150 mm amniocentesis needles among healthcare professionals"
100 to 150 mm needles are spearheading the type segment for amniocentesis needles market. The ergonomic features associated with it such as optimal length and availability in different gauge increase its popularity among healthcare professionals for collection of amniotic fluid. Larger than 150 mm needles are gaining huge traction as it enhances safety and ensures less needle punctures during transabdominal amniocentesis fluid collection in obese pregnant women with increased transabdominal thickness.
"Rising public health awareness and affordable healthcare services drive the hospital segment market growth"
Hospitals are dominating the end user segment for amniocentesis needles market. The chief contributing factors influencing its market growth are rising public health awareness regarding prenatal diseases and its effective diagnosis and availability of affordable healthcare services pertaining to obstetrics and gynecology. Diagnostic centers will be projecting impressive growth during the forecast period owing to availability of skilled workforce and advanced equipment utilized in prenatal diagnosis.
"Rising popularity of prenatal diagnosis and existence of major players together drive the market growth in North America"
In 2020, North America held market share of 34.7% and is leading the regional segment for amniocentesis needles market. The important criterions responsible for its dominating market growth are rising popularity of prenatal diagnosis in pregnant women and domicile of market leaders in the region such as CooperSurgical, Inc., Smiths Group, Plc. Medline Industries, Inc. Becton Dickinson & Company etc. Europe held a market share of 31.5% primarily due to effective implementation of health guidelines pertaining obstetrics and gynecology. Supportive regulatory environment provided by the European Medical Agency for the manufacture and sale of amniocentesis needles. Asia Pacific represents 25.2% market share owing to rise in disposable income, developing healthcare infrastructure and highly competitive environment for major players due to emerging local manufacturers of amniocentesis needles.
Medical device companies manufacturing amniocentesis needles are Becton Dickinson & Company, Biopsybell Srl, Cook Medical Incorporated, CooperSurgical, Inc., Laboratoire Ccd., Tsunami Medical S.r.l., Medline Industries, Inc., Ri.mos. S.r.l., Smiths Group, Plc. and Rocket Medical, Plc.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Amniocentesis Needles market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2022-2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Year | 2022 |
Unit | USD Million |
Segmentation | |
Type
| |
End User
| |
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report